These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 7736685

  • 21. Seasonal variation of lupus nephritis: high prevalence of class V lupus nephritis during the winter and spring.
    Schlesinger N, Schlesinger M, Seshan SV.
    J Rheumatol; 2005 Jun; 32(6):1053-7. PubMed ID: 15940767
    [Abstract] [Full Text] [Related]

  • 22. Glomerular expression of monocyte chemoattractant protein-1 is predictive of poor renal prognosis in pediatric lupus nephritis.
    Marks SD, Williams SJ, Tullus K, Sebire NJ.
    Nephrol Dial Transplant; 2008 Nov; 23(11):3521-6. PubMed ID: 18495743
    [Abstract] [Full Text] [Related]

  • 23. Dysregulation of apoptosis: a possible mechanism leading to chronic progressive renal histological changes in lupus nephritis.
    Lu F, Shen W, Zhang X, Guo M, Lin S.
    Chin Med J (Engl); 2000 Dec; 113(12):1082-6. PubMed ID: 11776141
    [Abstract] [Full Text] [Related]

  • 24. The difference between lupus nephritis class IV-G and IV-S in Koreans: focus on the response to cyclophosphamide induction treatment.
    Kim YG, Kim HW, Cho YM, Oh JS, Nah SS, Lee CK, Yoo B.
    Rheumatology (Oxford); 2008 Mar; 47(3):311-4. PubMed ID: 18204087
    [Abstract] [Full Text] [Related]

  • 25. Class V lupus nephritis: a clinicopathologic study in 152 patients.
    Chen Q, Liu Z, Hu W, Chen H, Zeng C, Li L.
    J Nephrol; 2003 Mar; 16(1):126-32. PubMed ID: 12653107
    [Abstract] [Full Text] [Related]

  • 26. Intravenous pulse cyclophosphamide treatment of severe lupus nephritis: a prospective five-year study.
    Valeri A, Radhakrishnan J, Estes D, D'Agati V, Kopelman R, Pernis A, Flis R, Pirani C, Appel GB.
    Clin Nephrol; 1994 Aug; 42(2):71-8. PubMed ID: 7955581
    [Abstract] [Full Text] [Related]

  • 27. Determinants of renal functional outcome in lupus nephritis: a single centre retrospective study.
    Chrysochou C, Randhawa H, Reeve R, Waldek S, Wood GN, O'Donoghue DJ, Kalra PA.
    QJM; 2008 Apr; 101(4):313-6. PubMed ID: 18270227
    [Abstract] [Full Text] [Related]

  • 28. Lupus nephritis in an anti-nuclear antibody-negative young male. The simultaneous presence of class III and class V renal lesions.
    Khajehdehi P, Islam SF, Salinas-Madrigal L, Bastani B.
    Clin Nephrol; 1999 Jun; 51(6):379-82. PubMed ID: 10404699
    [Abstract] [Full Text] [Related]

  • 29. [Urinary fibronectin as an indicator of kidney fibrosis in nephritis].
    Kozlovskaia LV, Bobkova IN, Varshavskiĭ VA, Proskurneva EP, Miroshnichenko NG, Chebotareva NV, Mukhin NA.
    Ter Arkh; 1999 Jun; 71(6):34-8. PubMed ID: 10420453
    [Abstract] [Full Text] [Related]

  • 30. Correlation of clinical and pathological findings in patients with lupus nephritis: a five-year experience in Iran.
    Nezhad ST, Sepaskhah R.
    Saudi J Kidney Dis Transpl; 2008 Jan; 19(1):32-40. PubMed ID: 18087120
    [Abstract] [Full Text] [Related]

  • 31. Microalbuminuria and renal morphology in the evaluation of subclinical lupus nephritis.
    Valente de Almeida R, Rocha de Carvalho JG, de Azevedo VF, Mulinari RA, Ioshhi SO, da Rosa Utiyama S, Nisihara R.
    Clin Nephrol; 1999 Oct; 52(4):218-29. PubMed ID: 10543324
    [Abstract] [Full Text] [Related]

  • 32. Experimental model of chronic serum sickness. Relationships between proteinuria, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and glomerular and extraglomerular renal pathology.
    Patrick CC, Virella G, Fudenberg HH.
    Arch Pathol Lab Med; 1980 Jun; 104(6):293-9. PubMed ID: 6990890
    [Abstract] [Full Text] [Related]

  • 33. Clinical usefulness of cellulose acetate electrophoresis as a screening of proteinuria in childhood.
    Hara M, Higuchi A, Tanizawa T, Suzuki Y, Okada T.
    Int J Pediatr Nephrol; 1985 Jun; 6(2):111-6. PubMed ID: 4030220
    [Abstract] [Full Text] [Related]

  • 34. [Lupus nephritis in children and adolescents (Part II: Prognosis)].
    Bogdanović R, Mikuska M, Cvorić A, Nikolić V, Sindjić M, Ognjanović M, Abinun M.
    Srp Arh Celok Lek; 1994 Jun; 122(5-6):155-7. PubMed ID: 17977415
    [Abstract] [Full Text] [Related]

  • 35. Predictive factors of clinical outcome in patients with diffuse proliferative lupus nephritis treated early by intravenous methylprednisolone pulse therapy.
    Kanno A, Hotta O, Yusa N, Taguma Y.
    Ren Fail; 2007 Jun; 29(1):41-7. PubMed ID: 17365909
    [Abstract] [Full Text] [Related]

  • 36. Lupus nephritis. Clinicopathological correlation.
    Al-Zahrani IH, Qayyum A.
    Saudi Med J; 2007 Oct; 28(10):1503-5. PubMed ID: 17914508
    [Abstract] [Full Text] [Related]

  • 37. Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis.
    Grootscholten C, Bajema IM, Florquin S, Steenbergen EJ, Peutz-Kootstra CJ, Goldschmeding R, Bijl M, Hagen EC, Van Houwelingen HC, Derksen RH, Berden JH, Dutch Working Party on Systemic Lupus Erythematosus.
    Arthritis Rheum; 2007 Mar; 56(3):924-37. PubMed ID: 17328070
    [Abstract] [Full Text] [Related]

  • 38. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis.
    Trendelenburg M, Lopez-Trascasa M, Potlukova E, Moll S, Regenass S, Frémeaux-Bacchi V, Martinez-Ara J, Jancova E, Picazo ML, Honsova E, Tesar V, Sadallah S, Schifferli J.
    Nephrol Dial Transplant; 2006 Nov; 21(11):3115-21. PubMed ID: 16877491
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Excretions of urinary albumin and various proteins increase in hypertension.
    Fujimoto T, Takechi S, Machida M, Isu N, Imamura W, Kakinoki S, Kanda K, Kobayashi T, Nomura A.
    Blood Press; 2008 Nov; 17(5-6):270-3. PubMed ID: 18821091
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.